MoKi Analytics GmbH is a start-up from Charité – University Medicine Berlin. The company was established in October 2017 by Dr. Judith Kikhney, biologist, and Prof. Dr. med. Annette Moter, specialized physician for microbiology and infectious diseases.
MoKi Analytics offers innovative products and services for the detection of microorganisms and biofilms by molecular biological methods, like FISH and PCR, sequencing and microbiome analysis. MoKi Analytics also offers standardized efficacy testing of antimicrobial products or devices.
Biofilms are organized microbial communities of bacteria and/or fungi. The biofilm offers advantages for the microorganisms, such as nutrition, recalcitrance against antibiotics, and protection from the host immune system.
Knowledge about biofilms is crucial for the development of effective prevention measures and therapeutic decision-making.
Routine methods of microbiology such as culturing of pathogens or molecular amplification techniques may identify the microbial species, but they are unable to detect the lifeform biofilm.